WEUSRTP4850: Phase II: ICS/LABA Use in Pregnancy and Outcomes

NCT01681979 · clinicaltrials.gov ↗
COMPLETED
Status
1
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline